These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 12851534)
41. Assessment of a portable prothrombin time analyzer (CoaguChek-XS) in dogs. Kelmer E; Segev G; Codner C; Bruchim Y; Klainbart S; Aroch I J Vet Emerg Crit Care (San Antonio); 2014; 24(4):455-60. PubMed ID: 25039332 [TBL] [Abstract][Full Text] [Related]
42. Prospective Comparison of Point-of-Care Device and Standard Analyzer for Monitoring of International Normalized Ratio in Outpatient Oral Anticoagulant Clinic. Moiz B; Rashid A; Hasan M; Jafri L; Raheem A Clin Appl Thromb Hemost; 2018 Oct; 24(7):1153-1158. PubMed ID: 29374969 [TBL] [Abstract][Full Text] [Related]
43. Therapeutic concordance of two portable monitors and two routine automatic oral anticoagulant monitoring systems using as reference the manual prothrombin time technique. Vacas M; Lafuente PJ; Unanue I; Santos M; Iriarte JA Hematol J; 2003; 4(3):214-7. PubMed ID: 12764354 [TBL] [Abstract][Full Text] [Related]
44. Inaccuracy of point-of-care international normalized ratio in rivaroxaban-treated patients. Baruch L; Sherman O Ann Pharmacother; 2013 Sep; 47(9):1210-2. PubMed ID: 24259738 [TBL] [Abstract][Full Text] [Related]
45. Acceptability of CoaguChek S and CoaguChek XS generated international normalised ratios against a laboratory standard in a paediatric setting. Williams VK; Griffiths AB Pathology; 2007 Dec; 39(6):575-9. PubMed ID: 18027261 [TBL] [Abstract][Full Text] [Related]
46. Point-of-care testing of the international normalized ratio in patients with antiphospholipid antibodies. Perry SL; Samsa GP; Ortel TL Thromb Haemost; 2005 Dec; 94(6):1196-202. PubMed ID: 16411394 [TBL] [Abstract][Full Text] [Related]
47. CoaguChek and Coag-Sense PT2 Meter Point of Care INR Device Validation. McBane RD; O'Connor C; Lutz J; Blanco J; Hartman LA; Kramer A; Uy J; Schumann T; Hartung K; Luker M; Hodge D; Santrach P; Karon BS Mayo Clin Proc; 2024 Jul; 99(7):1091-1100. PubMed ID: 38661594 [TBL] [Abstract][Full Text] [Related]
48. CoaguChek® XS versus standard laboratory prothrombin time for anticoagulant monitoring in patients with antiphospholipid syndrome. Fonseca MES; Balbi GGM; Signorelli F; Gouvea CP; de Andrade DCO Lupus; 2022 Apr; 31(5):565-574. PubMed ID: 35266798 [TBL] [Abstract][Full Text] [Related]
49. Accuracy of capillary whole blood international normalized ratio on the CoaguChek S, CoaguChek XS, and i-STAT 1 point-of-care analyzers. Karon BS; McBane RD; Chaudhry R; Beyer LK; Santrach PJ Am J Clin Pathol; 2008 Jul; 130(1):88-92. PubMed ID: 18550476 [TBL] [Abstract][Full Text] [Related]
50. Differences in warfarin dosing decisions based on international normalized ratio measurements with two point-of-care testing devices and a reference laboratory measurement. Shermock KM; Bragg L; Connor JT; Fink J; Mazzoli G; Kottke-Marchant K Pharmacotherapy; 2002 Nov; 22(11):1397-404. PubMed ID: 12432965 [TBL] [Abstract][Full Text] [Related]
52. A comparison of point-of-care instruments designed for monitoring oral anticoagulation with standard laboratory methods. Gosselin R; Owings JT; White RH; Hutchinson R; Branch J; Mahackian K; Johnston M; Larkin EC Thromb Haemost; 2000 May; 83(5):698-703. PubMed ID: 10823265 [TBL] [Abstract][Full Text] [Related]
53. Oral anticoagulant monitoring by laboratory or near-patient testing: what a clinician should be aware of. Tripodi A; Breukink-Engbers WG; van den Besselaar AM Semin Vasc Med; 2003 Aug; 3(3):243-54. PubMed ID: 15199457 [TBL] [Abstract][Full Text] [Related]
54. Comparative study of a portable monitor for prothrombin time determination, Coaguchek, with three systems for control of oral anticoagulant treatment. Vacas M; Lafuente PJ; Cuesta S; Iriarte JA Haemostasis; 1998; 28(6):321-8. PubMed ID: 10461015 [TBL] [Abstract][Full Text] [Related]
55. Quality assessment of CoaguChek point-of-care prothrombin time monitors: comparison of the European community-approved procedure and conventional external quality assessment. Poller L; Keown M; Ibrahim SA; van der Meer FJ; van den Besselaar AM; Tripodi A; Jespersen J; Meijer P; Kluft C; Clin Chem; 2006 Oct; 52(10):1843-7. PubMed ID: 16998117 [TBL] [Abstract][Full Text] [Related]
56. European Concerted Action on Anticoagulation. Correction of displayed international normalized ratio on two point-of-care test whole-blood prothrombin time monitors (CoaguChek Mini and TAS PT-NC) by independent international sensitivity index calibration. Poller L; Keown M; Chauhan N; Van Den Besselaar AM; Tripodi A; Shiach C; Jespersen J; Br J Haematol; 2003 Sep; 122(6):944-9. PubMed ID: 12956765 [TBL] [Abstract][Full Text] [Related]
57. Influence of haematocrit on international normalised ratio (INR) differences between a whole blood point-of-care coagulation monitor and reference prothrombin time in plasma. van den Besselaar AM; Witteveen E; van der Meer FJ Thromb Haemost; 2008 Dec; 100(6):1181-4. PubMed ID: 19132246 [TBL] [Abstract][Full Text] [Related]
58. A comparative study between INR and the determination of prothrombin time with the Coaguchek(r) portable coagulometer in the dental treatment of anticoagulated patients. Plaza-Costa A; Garcia-Romero P; Poveda-Roda R; Bagan JV; Silvestre-Donat FJ; Cervero JA Med Oral; 2002; 7(2):130-5. PubMed ID: 11887020 [TBL] [Abstract][Full Text] [Related]
59. Quality assurance program for whole blood prothrombin time-international normalized ratio point-of-care monitors used for patient self-testing to control oral anticoagulation. Tripodi A; Bressi C; Carpenedo M; Chantarangkul V; Clerici M; Mannucci PM Thromb Res; 2004; 113(1):35-40. PubMed ID: 15081563 [TBL] [Abstract][Full Text] [Related]
60. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms. Crowther MA Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]